Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 0.6400
0.00 (0.00%)
Jun 30, 2026, 5:18 PM CET
Safe Orthopaedics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.39 | 0.32 | 0.78 | 0.3 | 0.91 |
Cash & Short-Term Investments | 0.39 | 0.32 | 0.78 | 0.3 | 0.91 |
Cash Growth | 23.03% | -59.36% | 157.43% | -66.81% | -62.64% |
Accounts Receivable | 4.61 | 3.36 | 2.18 | 2.37 | 1.34 |
Inventory | 2.96 | 3.4 | 4.28 | 4.51 | 3.64 |
Other Current Assets | 0.45 | -0.07 | 1.22 | 2.08 | 2.36 |
Total Current Assets | 8.41 | 7 | 8.46 | 9.26 | 8.24 |
Net Property, Plant & Equipment | 2.01 | 2.5 | 3.57 | 5.28 | 4.55 |
Other Intangible Assets | 0.28 | 0.15 | 0.01 | 0.19 | 2.02 |
Goodwill | - | - | - | 1.79 | - |
Long-Term Investments | 0.11 | 0.11 | 0.15 | 0.1 | 0.06 |
Other Long-Term Assets | 1 | 1.27 | 65.74 | -0.1 | - |
Total Assets | 11.81 | 11.03 | 77.93 | 16.52 | 14.88 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.25 | 4.67 | 2.12 | 3.59 | 1.89 |
Short-Term Debt | 12.74 | 10.79 | - | 4.31 | - |
Current Portion of Long-Term Debt | - | - | 268.05 | - | 3.58 |
Current Portion of Leases | 0.17 | 0.17 | 0.36 | 0.51 | - |
Other Current Liabilities | 2.48 | 2.33 | 4.7 | 4.05 | 3.58 |
Total Current Liabilities | 20.65 | 17.96 | 275.24 | 12.45 | 9.04 |
Long-Term Debt | 0 | 0 | 1.51 | 3.43 | 5.28 |
Long-Term Leases | 0.59 | 0.83 | 1.28 | 1.64 | - |
Other Long-Term Liabilities | 1.25 | 0.67 | 2.25 | 0.27 | 0.16 |
Total Long-Term Liabilities | 1.84 | 1.5 | 5.04 | 5.35 | 5.44 |
Total Liabilities | 22.49 | 19.46 | 280.28 | 17.8 | 14.48 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.04 | 0.04 | 3.43 | 14.15 | 5.6 |
Treasury Stock | - | - | - | -0.08 | -0.08 |
Additional Paid-in Capital | 42.06 | 41.04 | 38.58 | 37.98 | 48.59 |
Accumulated Other Comprehensive Income | - | - | - | - | -0.42 |
Retained Earnings | -52.78 | -49.5 | -244.36 | -53.33 | -53.3 |
Total Common Shareholders' Equity | -10.68 | -8.42 | -202.35 | -1.28 | 0.4 |
Shareholders' Equity | -10.68 | -8.42 | -202.35 | -1.28 | 0.4 |
Total Liabilities & Equity | 11.81 | 11.03 | 77.92 | 16.52 | 14.88 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13.5 | 11.79 | 271.21 | 9.89 | 8.86 |
Net Cash (Debt) | -13.11 | -11.47 | -270.43 | -9.59 | -7.95 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.44 | - | -99.73 | - | - |
Book Value | -10.68 | -8.42 | -202.35 | -1.28 | 0.4 |
Book Value Per Share | -0.36 | - | -74.62 | - | - |
Tangible Book Value | -10.96 | -8.57 | -202.36 | -3.26 | -1.63 |
Tangible Book Value Per Share | -0.37 | - | -74.63 | - | - |